2m 2m 2m 2m 2m 2m 2m
OLEMA PHARMA (OLMA)
NASDAQ
$10.68-$0.01 (-0.14%)
Price as of Aug 21, 2026 7:43 PM EDT- $935.3MMarket Cap
- 85.59%1-Year Change
- BiotechnologyIndustry
OLEMA PHARMA (OLMA)
$10.68-$0.01 (-0.14%)
OLMA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.69 | ||
Change | -$0.21 (-1.93%) | ||
Open | $10.90 | ||
High | $11.24 | ||
Low | $10.65 | ||
Previous Close | $10.90 | ||
Volume | 748,704 | ||
30-Day Average Volume | 1,014,567 | ||
1-Week Change | 0.56% | ||
1-Month Change | -7.77% | ||
1-Year Change | 85.59% | ||
3-Year Change | 14.45% | ||
5-Year Change | -61.18% | ||
Fundamentals | |||
Shares Outstanding | 87.5M | ||
Total Assets | $486.6M | ||
Market Cap | $935.3M | ||
Enterprise Value | $889.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$63.2M | ||
Free Cash Flow | -$45.9M | ||
EBIT | -$63.2M | ||
EBITDA | -$63.1M | ||
Net Working Capital | $416.9M | ||
EPS | -$0.61 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -18 | ||
PEG | 1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue